Nektar Therapeutics (NKTR) — DEF 14A Filings

All DEF 14A filings from Nektar Therapeutics. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Nektar Therapeutics Files 2025 Proxy Statement — Apr 25, 2025 Risk: low
Nektar Therapeutics filed its definitive proxy statement (DEF 14A) on April 25, 2025, for its annual meeting scheduled for May 23, 2025. The filing outlines the
Nektar Therapeutics Announces 2024 Annual Meeting of Stockholders on June 5 — Apr 26, 2024 Risk: low
NEKTAR THERAPEUTICS (NKTR) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Nektar Therapeutics will hold its 2024 Annual Meeting of Stockholde

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX